| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 02/24/2010 | EP1325130B1 Nogo receptor homologs |
| 02/24/2010 | EP1200607B1 Tet repressor-based transcriptional regulatory proteins |
| 02/24/2010 | CN101654483A compositions and methods for generating chimeric heteromultimers |
| 02/24/2010 | CN101654479A Mammalian receptor proteins, agents, and methods relating thereto |
| 02/23/2010 | US7667016 nucleic acid compositions encoding a unique colorless protein, can be photoactivated, used in many biochemical, molecular biological and medical diagnostic applications |
| 02/23/2010 | US7667008 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 02/23/2010 | US7667000 Antibodies to Zcytor 16 |
| 02/23/2010 | US7666987 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 02/23/2010 | US7666839 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 02/23/2010 | US7666832 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666831 Administering peptibodies, i.e., peptides fused to other molecules such as an Fc domain of an antibody, where the peptide moiety specifically binds to Ang-2 ( angiopoietin-2); antiinflammatory agent; antirheumatic agent |
| 02/23/2010 | US7666626 P4 variant protein that has reduced enzymatic activity and that induces antibody to wild-type P4 protein and/or has good bactericidal activity against non-typable H. influenzae (NTHi) |
| 02/23/2010 | US7666621 Has an apparent molecular weight of 42,000 Daltons; fusion protein of the protein D bound to a polypeptide, carbohydrate, or matrix; prepared by providing a non-human host containing a plasmid or phage comprising a DNA nucleotide sequence and expressing the encoded protein D |
| 02/23/2010 | US7666430 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| 02/23/2010 | US7666422 Methods for the treatment of cancer using anti-CD40 antibodies |
| 02/23/2010 | US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 02/23/2010 | CA2344173C Immunogenic liposome compositions |
| 02/23/2010 | CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor |
| 02/18/2010 | WO2010019257A2 Prodrug activation in cancer cells using molecular switches |
| 02/18/2010 | WO2010018652A1 Agent for promoting neuronal differentiation and method therefor |
| 02/18/2010 | WO2010018444A2 An expression vector and a method thereof |
| 02/18/2010 | WO2009120893A3 Polypeptide-polymer conjugates and methods of use thereof |
| 02/18/2010 | US20100041028 Zinc finger binding domains for GNN |
| 02/18/2010 | US20100040627 Baff receptor (bcma), an immunoregulatory agent |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | CA2736580A1 An expression vector and a method thereof |
| 02/18/2010 | CA2732882A1 Production, formulation, and uses of stable liquid harpin protein formulations |
| 02/17/2010 | EP2154535A1 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2010 | EP2154251A1 Expression system of recombinant proteins with enhanced yield and immunogenicity |
| 02/17/2010 | EP2154248A1 Compounds and methods for diagnosis of tuberculosis |
| 02/17/2010 | EP2154159A1 Activated protease indicator |
| 02/17/2010 | EP2154154A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 02/17/2010 | EP2153843A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/17/2010 | CN100590133C Growth hormone and serum albumni recombinant fusion protein |
| 02/16/2010 | US7662782 Melanocortin 1 receptor selective compounds |
| 02/16/2010 | US7662633 Method of screening for inhibitors of osteopontin |
| 02/16/2010 | US7662557 Methods for producing members of specific binding pairs |
| 02/16/2010 | US7662410 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 02/16/2010 | US7662391 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines |
| 02/16/2010 | US7662383 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction |
| 02/16/2010 | CA2224444C Type f botulinum toxin and use thereof |
| 02/11/2010 | WO2010015036A1 Biological applications of steroid binding domains |
| 02/11/2010 | WO2009136298A3 Compositions and methods for inhibiting shiga toxin and shiga-like toxin |
| 02/11/2010 | US20100035237 Novel antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 02/11/2010 | US20100035236 Enrichment method for variant proteins with altered binding properties |
| 02/11/2010 | US20100034842 Compositions Employing Alternative Reading Frame Polypeptides for the Treatment of Cancer and Infectious Disease |
| 02/11/2010 | CA2733506A1 Biological applications of steroid binding domains |
| 02/11/2010 | CA2733425A1 Vaccines against clostridium difficile and methods of use |
| 02/11/2010 | CA2732449A1 Fgfr extracellular domain acidic region muteins |
| 02/10/2010 | EP2151244A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/10/2010 | CN101643512A Novel immunoadhesin for the prevention of rhinovirus infection |
| 02/10/2010 | CN101643511A Fusion protein for inhibiting telomerase activity, preparation and application thereof |
| 02/09/2010 | US7659385 Polynucleotides encoding molecules designated LDCAM |
| 02/09/2010 | US7659368 ErbB2 and ErbB3 chimeric heteromultimer adhesins |
| 02/09/2010 | US7659117 Immunostimulatory fusion proteins comprising polypeptide antigen for generating protective DC-induced T-cell-mediated immune responses; metastatic cancers |
| 02/09/2010 | US7658934 Chlamydia antigens and protein vaccine |
| 02/09/2010 | US7658919 Fusion polypeptide; includes a first polypeptide that is glycosylated by a alpha 1, 3/4 fucosyltransferase (FUT3), an alpha 1,2 fucosyltransferase (FUT2) and a beta 1,3 galactosyltransferase operably linked to a second polypeptide |
| 02/09/2010 | CA2404945C Taci as an anti-tumor agent |
| 02/09/2010 | CA2350417C Dna-protein fusions and uses thereof |
| 02/09/2010 | CA2349875C Dna encoding a growth factor specific for epithelial cells |
| 02/04/2010 | WO2010014922A2 Protein purification tags and uses thereof |
| 02/04/2010 | US20100028367 Sgp130/fc dimers |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | CA2732574A1 Multi-specific binding proteins targeting b cell disorders |
| 02/03/2010 | EP2148889A1 Modified plant defensin |
| 02/03/2010 | CN101638440A Heterogenetic antigen-Fc fusion protein capable of inducing antitumor immunity of organism and application thereof |
| 02/03/2010 | CN101638437A Growth hormone fusion protein |
| 02/03/2010 | CN100586961C Fusion protein having inhibitory action on tumour cell and its coding gene and application |
| 02/03/2010 | CN100586959C Peptides capable of binding to titanium, silver and silicone |
| 02/02/2010 | US7655617 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 02/02/2010 | US7655422 Using g-protein coupled receptor as tools in identifying modulators which improve palatability of low-calorie beverages through development of new artificial sweeteners |
| 02/02/2010 | US7655412 Useful to form complexes having an affinity to targets of interest; verotoxin subunit B |
| 02/02/2010 | US7655249 vaccine including a polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 02/02/2010 | US7655238 Fusing to the antigen a Listerial truncated ActA protein; Listeria vaccine strains |
| 02/02/2010 | CA2479494C Compositions and methods associated with pro5725 and its use for the diagnosis of lung and colon tumor |
| 02/02/2010 | CA2293724C Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 01/28/2010 | WO2010011096A2 A polypeptide complex comprising non-peptidyl polymer having three functional ends |
| 01/28/2010 | US20100022760 Mutant protein |
| 01/28/2010 | US20100022759 Polymer and fluorescence probe having the polymer |
| 01/28/2010 | US20100021482 Novel death associated proteins, and thap1 and par4 pathways in apoptosis control |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021462 Gasp1: a follistatin domain containing protein |
| 01/28/2010 | CA2731546A1 A polypeptide complex comprising non-peptidyl polymer having three functional ends |
| 01/28/2010 | CA2730132A1 Novel angiopoietin derived peptides |
| 01/27/2010 | EP2147679A2 Compositions and methods for modulating blood-brain barrier transport |
| 01/27/2010 | EP1692186B1 Cancer cell targeting gene delivery method |
| 01/27/2010 | EP1362106B1 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 01/27/2010 | CN101636415A Method and means for concentrating, removing, and detecting gram-positive bacteria |
| 01/27/2010 | CN101633699A New type antibiotic containing an antibody analog, preparation method and application method thereof |
| 01/27/2010 | CN101633698A Immune fusion protein and gene encoding same and application thereof |
| 01/27/2010 | CN100584945C Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 01/26/2010 | CA2421588C Tnf receptor-like molecules and uses thereof |
| 01/21/2010 | WO2010009440A2 Non-invasive fetal rhd genotyping from maternal whole blood |
| 01/21/2010 | WO2010009227A2 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 01/21/2010 | WO2010008010A1 Hcv/gbv-b chimeric virus |
| 01/21/2010 | WO2010007724A1 Peptide capable of binding to epcam |
| 01/21/2010 | WO2010007723A1 Peptide capable of binding to ceramic material |
| 01/21/2010 | WO2010006447A1 Chimeric respiratory syncytial virus polypeptide antigens |